Skip to main content

Innovation. Clarity. Execution.  I  Exit History

Exit History.

Delivering Value

2022

2021

Filter

Aura
Aura

Aura

IPO NASDAQ

2020

Filter

Kandy
Kandy

Kandy

Aquired by Bayer $875M + milestones

2019

Filter

CardiAQ
CardiAQ

CardiAQ

Acquired by Edwards Lifesciences Corporation USD $400M

2018

Filter

2017

Filter

2016

Filter

SEP
SEP

SEP

Acquired by Juno Aspire Pharma

2014

Filter

Agenus
Agenus

Agenus

4-Antibody acquired by Agenus
Algeta
Algeta

Algeta

Acquired by Bayer USD $2.9B

2013

Filter

CN
CN

CN

Acquired by British American Tobacco
Santarus
Santarus

Santarus

Acquired by Salix Pharmaceuticals Inc. USD $2.6B

2012

Filter

Micromet
Micromet

Micromet

NASDAQ. Acquired by Amgen USD$1.1b
Avila
Avila

Avila

Acquired by Celgene USD$350m + USD$575m milestones
EUSA
EUSA

EUSA

Acquired by Jazz Pharmaceuticals USD$700m

2011

Filter

Cardiokine
Cardiokine

Cardiokine

Acquired by Cornerstone

2010

Filter

2009

Filter

Emergent
Emergent

Emergent

Merged with Microscience

2008

Filter

Thiakis
Thiakis

Thiakis

Acquired by Wyeth Pharmaceuticals USD$150m

2007

Filter

Algeta
Algeta

Algeta

IPO Oslo Børs

2006

The companies in which we have invested since the year 2006 have discovered and developed, fourteen approved medicines and products to the benefit of patients, physicians and our investors.

Portfolio

About

Leading Venture Investors
Learn More

Portfolio

Innovative Life Sciences Companies
Learn More